Head-to-head · WeighScore
Ro vs AgelessRx
The verdict
AgelessRx takes it — 84/100 to 78/100.
AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the lowest compounded-semaglutide pricing, with some brand-name access.
Partner links are labeled — we may earn a commission at no cost to you. It never changes the grade.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ro | AgelessRx |
|---|---|---|
| WeighScore | 78/100 | 84/100 |
| Grade | C+ | B |
| Scorecard rank | #24 | #11 |
| Semaglutide | Not disclosed | $139/mo |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Multi-state | Not disclosed |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Injection only |
| Relationship | Editorial | Partner |
Graded #24 · C+
Strengths
- Brand-name access + insurance support
- Oral options
- Well-funded platform
Where it loses points
- Does not disclose compounded pricing up front
- Premium positioning
Graded #11 · B
Strengths
- Low-end semaglutide pricing
- Some brand-name access
- Established brand
Where it loses points
- Tirzepatide pricing not disclosed
- States not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 25 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.